DEC1 anticorps (AA 350-412)
-
- Antigène Voir toutes DEC1 Anticorps
- DEC1 (Deleted in Esophageal Cancer 1 (DEC1))
-
Épitope
- AA 350-412
- Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp DEC1 est non-conjugé
-
Application
- Western Blotting (WB), Immunoprecipitation (IP)
- Réactivité croisée
- Humain
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu
- Attributs du produit
- DEC1 (DEC-1, Differentially Expressed in Chondrocytes, Differentiated Embryo Chrondrocyte Expressed Gene 1, BHLHB2, Basic Helix-Loop-Helix Domain Containing Class B 2, SHARP2, SHARP-2, STRA13, STRA14)
- Purification
- Purified by immunoaffinity chromatography.
- Immunogène
- Synthetic peptide corresponding to a region between aa350-412 of the C-terminus of human DEC1 (Accession # NP_003661.1).
- Isotype
- IgG
- Top Product
- Discover our top product DEC1 Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied as a liquid, 0.09 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C
- Stockage commentaire
- 4°C ,Do Not Freeze
-
- Antigène
- DEC1 (Deleted in Esophageal Cancer 1 (DEC1))
- Autre désignation
- DEC1 (DEC1 Produits)
- Synonymes
- anticorps CTS9, anticorps DEC1, anticorps deleted in esophageal cancer 1, anticorps DEC1
- NCBI Accession
- NP_003661
-